Part Details | THEOPHYLLINE EXTENDED-RELEASE TABLETS
6505-01-037-5613
Alternate Parts: NDC00258358401, NDC00258-3584-01, NDC00258358401, NDC00258-3584-01, THEODUR TABLETS, THEO-DUR TABLETS, THEODUR, THEO-DUR, NDC00085048701, NDC00085-0487-01, NDC50111048301, NDC50111-0483-01, 6505-01-037-5613, 01-037-5613, 6505010375613, 010375613
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 21, 1977 | 01-037-5613 | 42612 ( THEOPHYLLINE EXTENDED-RELEASE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-037-5613
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00258-3584-01 | 65050 | FOREST PHARMACEUTICALS INCSUB OF FOREST LABORATORIES INC |
| NDC00258-3584-01 | 6X308 | INWOOD LABORATORIES INC |
| THEO-DUR TABLETS | 1F095 | SCHERING-PLOUGH CORPORATION |
| THEO-DUR | 1F095 | SCHERING-PLOUGH CORPORATION |
| NDC00085-0487-01 | 1F095 | SCHERING-PLOUGH CORPORATION |
| NDC50111-0483-01 | 1BL76 | SIDMAK LABORATORIES INC |
Technical Data | NSN 6505-01-037-5613
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB100.000 MILLIGRAMS THEOPHYLLINE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| THERAPEUTIC EQUIVALENT | THEO-DUR BY SCHERING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE TABLETS 100MG 100S BT |